Zobrazeno 1 - 4
of 4
pro vyhledávání: '"R. Dirkson"'
Autor:
S. Hanumanthu, B. Vogel, R. Müller, S. Brunamonti, S. Fadnavis, D. Li, P. Ölsner, M. Naja, B. B. Singh, K. R. Kumar, S. Sonbawne, H. Jauhiainen, H. Vömel, B. Luo, T. Jorge, F. G. Wienhold, R. Dirkson, T. Peter
Publikováno v:
Atmospheric Chemistry and Physics, Vol 20, Pp 14273-14302 (2020)
The South Asian summer monsoon is associated with a large-scale anticyclonic circulation in the upper troposphere and lower stratosphere (UTLS), which confines the air mass inside. During boreal summer, the confinement of this air mass leads to an ac
Externí odkaz:
https://doaj.org/article/ed441bd66d3345bb9cb3ed6a7dd9306b
Autor:
Jolanda Derks, Anne R. Dirkson, Philip C. de Witt Hamer, Quinten van Geest, Hanneke E. Hulst, Frederik Barkhof, Petra J.W. Pouwels, Jeroen J.G. Geurts, Jaap C. Reijneveld, Linda Douw
Publikováno v:
NeuroImage: Clinical, Vol 14, Iss C, Pp 87-96 (2017)
Gliomas are primary brain tumors, originating from the glial cells in the brain. In contrast to the more traditional view of glioma as a localized disease, it is becoming clear that global brain functioning is impacted, even with respect to functiona
Externí odkaz:
https://doaj.org/article/5fd77e22d0e543c4b5b7dd39354d7afc
Autor:
Dide den Hollander, Anne R. Dirkson, Suzan Verberne, Wessel Kraaij, Gerard van Oortmerssen, Hans Gelderblom, Astrid Oosten, Anna K. L. Reyners, Neeltje Steeghs, Winette T. A. van der Graaf, Ingrid M. E. Desar, Olga Husson
Publikováno v:
Supportive Care in Cancer, 30, 5137-5146
Supportive Care in Cancer
Supportive Care in Cancer, 30(6), 5137-5146. SPRINGER
Supportive Care in Cancer, 30(6), 5137-5146. Springer-Verlag
Supportive Care in Cancer. SPRINGER
Supportive Care in Cancer, 30, 6, pp. 5137-5146
Supportive Care in Cancer
Supportive Care in Cancer, 30(6), 5137-5146. SPRINGER
Supportive Care in Cancer, 30(6), 5137-5146. Springer-Verlag
Supportive Care in Cancer. SPRINGER
Supportive Care in Cancer, 30, 6, pp. 5137-5146
Purpose Treatment with the tyrosine kinase inhibitor (TKI) imatinib in patients with gastrointestinal stromal tumours (GIST) causes symptoms that could negatively impact health-related quality of life (HRQoL). Treatment-related symptoms are usually c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.